136 related articles for article (PubMed ID: 22348555)
1. In vivo versus in vitro individual radiosensitivity analysed in healthy donors and in prostate cancer patients with and without severe side effects after radiotherapy.
Brzozowska K; Pinkawa M; Eble MJ; Müller WU; Wojcik A; Kriehuber R; Schmitz S
Int J Radiat Biol; 2012 May; 88(5):405-13. PubMed ID: 22348555
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal radiosensitivity analyzed by FISH in lymphocytes of prostate cancer patients and healthy donors.
Schmitz S; Brzozowska K; Pinkawa M; Eble M; Kriehuber R
Radiat Res; 2013 Nov; 180(5):465-73. PubMed ID: 24083681
[TBL] [Abstract][Full Text] [Related]
3. Prediction of radiation-induced toxicity by in vitro radiosensitivity of lymphocytes in prostate cancer patients.
Pinkawa M; Brzozowska K; Kriehuber R; Eble MJ; Schmitz S
Future Oncol; 2016 Mar; 12(5):617-24. PubMed ID: 26806671
[TBL] [Abstract][Full Text] [Related]
4. G2 Chromosomal Radiosensitivity Assay for Testing Individual Radiation Sensitivity.
Haskins JS; Kato TA
Methods Mol Biol; 2019; 1984():39-45. PubMed ID: 31267418
[TBL] [Abstract][Full Text] [Related]
5. Cell death mechanisms associated with G2 radiosensitivity in patients with prostate cancer and benign prostatic hyperplasia.
Howe O; O'Malley K; Lavin M; Gardner RA; Seymour C; Lyng F; Mulvin D; Quinlan DM; Mothersill C
Radiat Res; 2005 Nov; 164(5):627-34. PubMed ID: 16238439
[TBL] [Abstract][Full Text] [Related]
6. Induction and disappearance of G2 chromatid breaks in lymphocytes after low doses of low-LET gamma-rays and high-LET fast neutrons.
Vral A; Thierens H; Baeyens A; De Ridder L
Int J Radiat Biol; 2002 Apr; 78(4):249-57. PubMed ID: 12020436
[TBL] [Abstract][Full Text] [Related]
7. A standardized G2-assay for the prediction of individual radiosensitivity.
Pantelias GE; Terzoudi GI
Radiother Oncol; 2011 Oct; 101(1):28-34. PubMed ID: 22014898
[TBL] [Abstract][Full Text] [Related]
8. The potential role of G2- but not of G0-radiosensitivity for predisposition of prostate cancer.
Borgmann K; Raabe A; Reuther S; Szymczak S; Schlomm T; Isbarn H; Gomolka M; Busjahn A; Bonin M; Ziegler A; Dikomey E
Radiother Oncol; 2010 Jul; 96(1):19-24. PubMed ID: 20452694
[TBL] [Abstract][Full Text] [Related]
9. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal radiosensitivity in Ukrainian breast cancer patients and healthy individuals.
Ryabchenko NM; Glavin OA; Shtefura VV; Anikushko MF
Exp Oncol; 2012 Jul; 34(2):121-4. PubMed ID: 23013765
[TBL] [Abstract][Full Text] [Related]
11. G2-checkpoint abrogation in irradiated lymphocytes: A new cytogenetic approach to assess individual radiosensitivity and predisposition to cancer.
Terzoudi GI; Hatzi VI; Barszczewska K; Manola KN; Stavropoulou C; Angelakis P; Pantelias GE
Int J Oncol; 2009 Nov; 35(5):1223-30. PubMed ID: 19787278
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal aberrations and in vitro radiosensitivity: intra-individual versus inter-individual variability.
Vral A; Thierens H; Baeyens A; De Ridder L
Toxicol Lett; 2004 Apr; 149(1-3):345-52. PubMed ID: 15093280
[TBL] [Abstract][Full Text] [Related]
13. Prediction of late normal tissue complications in RT treated gynaecological cancer patients: potential of the gamma-H2AX foci assay and association with chromosomal radiosensitivity.
Werbrouck J; De Ruyck K; Beels L; Vral A; Van Eijkeren M; De Neve W; Thierens H
Oncol Rep; 2010 Feb; 23(2):571-8. PubMed ID: 20043123
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition.
Baeyens A; Thierens H; Claes K; Poppe B; Messiaen L; De Ridder L; Vral A
Br J Cancer; 2002 Dec; 87(12):1379-85. PubMed ID: 12454765
[TBL] [Abstract][Full Text] [Related]
15. G2 chromatid breaks in murine SCID cells.
Bryant PE; Finnegan CE; Swaffield L; Mozdarani H
Mutagenesis; 1998 Sep; 13(5):481-5. PubMed ID: 9800193
[TBL] [Abstract][Full Text] [Related]
16. Predicting Radiosensitivity with Gamma-H2AX Foci Assay after Single High-Dose-Rate and Pulsed Dose-Rate Ionizing Irradiation.
van Oorschot B; Hovingh S; Dekker A; Stalpers LJ; Franken NA
Radiat Res; 2016 Feb; 185(2):190-8. PubMed ID: 26789702
[TBL] [Abstract][Full Text] [Related]
17. G2-phase chromosomal radiosensitivity of primary fibroblasts from hereditary retinoblastoma family members and some apparently normal controls.
Wilson PF; Nagasawa H; Fitzek MM; Little JB; Bedford JS
Radiat Res; 2010 Jan; 173(1):62-70. PubMed ID: 20041760
[TBL] [Abstract][Full Text] [Related]
18. Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays.
Scott D; Barber JB; Spreadborough AR; Burrill W; Roberts SA
Int J Radiat Biol; 1999 Jan; 75(1):1-10. PubMed ID: 9972785
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation.
Kong Z; Xie D; Boike T; Raghavan P; Burma S; Chen DJ; Habib AA; Chakraborty A; Hsieh JT; Saha D
Cancer Res; 2010 Apr; 70(7):2829-39. PubMed ID: 20332235
[TBL] [Abstract][Full Text] [Related]
20. The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repair.
Kasten-Pisula U; Menegakis A; Brammer I; Borgmann K; Mansour WY; Degenhardt S; Krause M; Schreiber A; Dahm-Daphi J; Petersen C; Dikomey E; Baumann M
Radiother Oncol; 2009 Feb; 90(2):257-64. PubMed ID: 19038467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
